Freebies for Subject 641: A Discussion of the Ethical Prospect of Providing Drug Trial Subjects With Post-Trial Access to the Drug Tested -- a Canadian Perspective
Hutt, Leah E.
Health Law Journal 1998; 6: 169-187
Showing items related by title, author, creator and subject.
Post-Trial Access to Tested Interventions: The Views of IRB/REC Chair, Investigators, and Research Participants in a Multinational HIV/AIDS Study Pace, Christine; Grady, Christine; Wendler, David; Bebchuk, Judith D.; Tavel, Jorge A.; McNay, Laura A.; Forster, Heidi P.; Killen, Jack; Emanuel, Ezekiel J. (Espirit Group, 2006-09)
Subjects' Views of Obligations to Ensure Post-Trial Access to Drugs, Care and Information: Qualitative Results From the Experiences of Participants in Clinical Trials (EPIC) Study Sofaer, N.; Thiessen, C.; Goold, S.D.; Ballou, J.; Getz, K.A.; Koski, G.; Krueger, R.A.; Weissman, J.S. (2009-03)OBJECTIVES: To report the attitudes and opinions of subjects in US clinical trials about whether or not, and why, they should receive post-trial access (PTA) to the trial drug, care and information. DESIGN: Focus groups, ...
Millum, Joseph (2011-03)Many recent articles argue that participants who seroconvert during HIV prevention trials deserve treatment when they develop AIDS, and there is a general consensus that the participants in HIV/AIDS treatment trials should ...